baber/WOPTO huggingface dataset:
Patent UA-73358-C2 (UA)
Title: Method for treatment of hydrophobic beds
Inventor: KOPACH IHOR VASYLIOVYCH
IPC: E21B43/22
Filed: 2002-12-28
Abstract: This invention relates to oil-gas production industry, in particular to technology of treatment of wells with surface-active substances (SAS). The method for treatment of hydrophobic beds includes pumping-in to the well a hydrocarbon solution of nonionic surface-active substance (NSAS), this includes 3.0 û 6.0 mass % of NSAS, like fatox or ripox, 1 û 10 mass % of methanol or 1 û 3 mass % of mono-ethyl-amine and condensate or light oil (up to 100 mass %); at that pumping-in of the solution is performed through sequential implementation of the stage of pumping-in solution and the stage of capillary saturation of the well bottom zone. In the wells with content of asphalt-tar-paraffin substances in oil more than 5 % treatment is repeated 2-6 times per year. Effectiveness is increased for hydrophobic beds and the beds that product at the same time water and oil.
Patent UA-72397-C2 (UA)
Title: Anti-filtration system for immersed part of structure
Inventor: LADYCHUK DMYTRO OLEKSANDROVYCH
IPC: E04B1/64
Filed: 2003-12-19
Abstract: The anti-filtration system for the immersed part of the structure has a barrier formed by a wall placed in the under-soil, this has a screen placed in its base and adjoining its lower end. According to the invention the immersed part of the structure, at the perimeter and at the beneath, is protected with a continuous clay screen. The anti-filtration system has as well a water collector, this is filled by ? of its volume by water-permeable filling soil, and its upper part has a free air area closed with lining, this has air exchange elements, and the system of discharge of the water accumulated in the water collector, this comprises threads of the heat-conductive electric cable, the number and the grade of those depend on the depth of the immersed part of the structure.
Patent UA-78306-C2 (UA)
Title: Veterinary biologically active additive and method for reparative therapy in dyspepsia of newborn calves
Inventor: MELNYCHUK DMYTRO OLEKSIIOVYCH
IPC: A61K31/198
Filed: 2004-11-02
Abstract: The invention relates to the veterinary, in particular to the veterinary biologically active additive (BAA) and the method for the reparative therapy in dyspepsia of the newborn calves. The proposed BAA contains the lipid mixture of the phospholipids (butter whey); the mixture of unsaturated fatty acids (oleinic, linolic, and linolenic); and methionine taken at a 1:0.7:0.56 ratio. The composition also contains 8 mg of alpha tocopherol and 2800 IU of retinol acetate per 1 g of the lipid mixture. The also invention relates to the method for the reparative therapy in dyspepsia of the newborn calves providing for the oral use of the proposed BAA in the setting of the conventional therapy.
Patent DK-31684-D0 (DK)
Inventor: BASCHANG GERHARD
IPC: C07K5/06
Filed: 1984-01-24
Abstract: The invention relates to lipopeptides of the formula I,    <IMAGE> (I)  * = -R** = -R or -S*** = -R  in which each of Ra1 and Rb1, independently of the other, represents an aliphatic or cycloaliphatic-aliphatic hydrocarbon radical having from 7 to 21 carbon atoms that is optionally substituted by oxygen functions, or one of the radicals Ra1-CO- and Rb1-CO- represents hydrogen and the other of the radicals Ra1-CO- and Rb1-CO- represents an acyl radical, wherein Ra1 and Rb1 have the meanings given above, R2 represents an aliphatic or cycloaliphatic-aliphatic hydrocarbon radical having from 1 to 21 carbon atoms that is optionally substituted by oxygen functions, n=0 or 1, As DEG  represents a radical of the formula -O-Kw-CO- or -NH-Kw-CO- wherein Kw represents an aliphatic hydrocarbon radical having a maximum of 12 carbon atoms, As1 represents a D- or L- alpha -amino acid, each of Z1 and Z2, independently of the other, represents hydroxy or the N-terminal radical of a D- or L- alpha -aminocarboxylic acid, of an amino-lower alkanesulphonic acid or of a peptide having a maximum of 6 amino acids from the group consisting of D- or L- alpha -aminocarboxylic acids and amino-lower alkanesulphonic acids, and Z3 represents hydrogen or -CO-Z4 wherein Z4 represents hydroxy or the N-terminal radical of a D- or L- alpha -amino acid, of an amino-lower alkanesulphonic acid or of a peptide having a maximum of 6 amino acids from the group consisting of D- or L- alpha -aminocarboxylic acids and amino-lower alkanesulphonic acids, and the amides and esters of such compounds that contain carboxy groups. The novel lipopeptides have an immunity-stimulating action.
Patent DK-109683-D0 (DK)
Inventor: SCHROEDTER KLAUS
IPC: C01B25/40
Filed: 1983-03-04
Abstract: The disclosure relates to a process for making linear, substantially water-insoluble ammonium polyphosphates of the general formula (NH4PO3)10-1000 by heating and continuously mixing phosphorus pentoxide and ammonium orthophosphate in the presence of ammonia and tempering the resulting reaction product over a period of several hours at 200 DEG  to 400 DEG  C. in the presence of ammonia. To this end, the phosphorus pentoxide and ammonium orthophosphate are subjected at 50 DEG  to 150 DEG  C. to the following successive operations which provide (a) for them to be reacted with ammonia over a period of 5 to 15 minutes under an overpressure of 1-2 millibars, (b) for them to be mixed under nitrogen for 10 to 60 minutes at atmospheric pressure while arresting the supply of ammonia, (c) for them to be reacted with ammonia over a period of 1 to 3 hours under a pressure 1 to 5 millibars lower than atmospheric pressure, and the reaction product is tempered, the ammonia being used in an overall stoichiometric excess of at most 20 mol %. The disclosure is also concerned with the ammonium polyphosphates so obtainable which are characterized by the following typical data which provide: (a) for the solubility of a 10 weight % suspension in pure water at 25 DEG C. to be less than 0.8 g per 100 g suspension; (b) for the viscosity of a 10 weight % suspension in pure water at 25 DEG  C. to be at most 100 mPa.s; (c) for the viscosity of a 30 weight % suspension in a polyesterpolyol at 25 DEG  C. to be at most 50 Pa.s.
Patent DK-196686-D0 (DK)
Inventor: FISHER ABRAHAM
IPC: C07D497/20
Filed: 1986-04-29
Abstract: Quinuclidine derivatives having the general formula (I)  <IMAGE>  and geometrical isomers, enantiomers, diastereoisomers, racemates and/or acid addition salts thereof, wherein Z represents the group >CR1R2 or two hydrogen atoms; and R1 and R2, which may be identical or different, are each alkyl, cyclopentyl, cyclohexyl, aryl, or diarylmethylol, or alkyl which is substituted by one or more aryl groups, or one of R1 and R2 may be hydrogen.
Patent DK-227787-D0 (DK)
Inventor: HEAVNER GEORGE
IPC: C07K/
Filed: 1987-05-04
Abstract: Solution phase methods and compositions for preparing H-ARG-X-Z-Y-TYR-R wherein X is LYS and Y is VAL or X and Y are both SAR, Z is ASP or GLU, and R is NH<sub>2</sub> or OH.
Patent DK-254889-D0 (DK)
Inventor: JOHANSSON HANS ERIK
IPC: D21H17/44
Filed: 1989-05-25
Abstract: A process for the production of paper by forming and dewatering a suspension of cellulose containing fibres, and optional fillers, on a wire. The forming and dewatering is carried out in the presence of a combination of an aluminum compound, a cationic retention agent and a polymeric silicic acid having a high specific surface area. The combination of substances improves dewatering and retention of fines and fillers.
Patent DK-266383-D0 (DK)
Inventor: MACK ROBERT
IPC: F24J3/00
Filed: 1983-06-10
Abstract: In an absorption heat pump capable of bivalent operation, to make possible a combined operation in addition to the pure heat pump operation and the pure boiler operation, it is proposed to divide the refrigerant stream after the condenser and the stream of weak solution leaving the boiler, with one component stream of the refrigerant being fed through the refrigerant throttle and the vaporizer to a low-pressure absorber, into which a component stream of the weak solution is introduced through the temperature changer and the solvent throttle, while the other component stream of the refrigerant is fed either directly to the boiler or to a high-pressure absorber, to which the other component stream of the weak solution is fed directly in both cases, and to feed the strong solution from the low-pressure absorber through the temperature changer and/or the reflux condenser to the boiler, but on the other hand to feed the solution from the high-pressure absorber directly to the boiler.
Patent DK-295188-D0 (DK)
Inventor: HOEOEK MAGNUS
IPC: A61K38/16
Filed: 1988-05-31
Abstract: The present invention relates to a new recombinant hybrid-DNA-molecule comprising a nucleotide sequence from S. aureus coding for a protein, or polypeptide, having fibronectin binding properties.
Patent DK-386388-D0 (DK)
Inventor: RISTELI JUHA
IPC: G01N33/68
Filed: 1988-07-11
Abstract: A trimeric aminoterminal propeptide of type III procollagen free of proteolytic activity that could degrade the propeptide may be used to produce an antibody specific to the trimeric propeptide and which has no affinity for the monomeric degraded propeptide. This antibody may be used to assay more accurately propeptide which is a measure of rate of production of collagen, which is useful in diagnosing e.g. fibrosis.
Patent DK-561484-D0 (DK)
Inventor: PETZOLDT KARL
IPC: A61K31/16
Filed: 1984-11-27
Abstract: Indanyl compounds of the formula   <IMAGE>   wherein R1 and R2 are hydrogen, fluorine or chlorine, is useful in the treatment of inflammatory and allergic diseases are prepared by fermenting indanyl compounds of the formula   <IMAGE>  with a culture of Aspergillus niger or Polyporus tulipiferus.
Patent DK-688488-D0 (DK)
Inventor: JAEGGI KNUT A
IPC: C07F9/38
Filed: 1988-12-09
Abstract: Araliphatylaminoalkanediphosphonic acids of the formula <IMAGE> in which R1 represents an aromatically substituted aliphatic radical, R2 represents hydrogen or a monovalent aliphatic radical and alk denotes a divalent aliphatic radical, and their salts have a marked regulating action on calcium metabolism and can be used as medicaments for the treatment of diseases which can be traced back to disorders thereof. They are prepared, for example, by reacting a compound of the formula <IMAGE> in which X3 denotes carboxyl and R0 denotes a radical R2, with phosphorous acid and phosphorus trichloride and hydrolysing the primary product.
Patent HU-901444-D0 (HU)
Title: Process for producing basic aluminium compounds
Inventor: DORE FAUSTO
IPC: C01F7/786
Filed: 1990-01-10
Abstract: PCT No. PCT/EP90/00050 Sec. 371 Date Sep. 18, 1990 Sec. 102(e) Date Sep. 18, 1990 PCT Filed Jan. 10, 1990 PCT Pub. No. WO90/08738 PCT Pub. Date Aug. 9, 1990.The present invention relates to a process for preparing basic aluminum compounds having the general formula (1) [Al2 (OH)x Cly (SO4)z]n (1) where: n is at least equal to 1 x=2-4.0 y=2.0-3.40 z=0-0.30 and x+y+z=6 by means of a reaction of alumina with hydrochloric acid, possibly mixed with sulfuric acid. The alumina is caused to react in alumina/acid(s) stoichiometric conditions to obtain the compounds of formula (1). The reaction is carried out by milling alumina in liquid phase under heavy stirring.
Patent HU-9202354-D0 (HU)
Title: Method for reactivation of denatured protein
Inventor: AMBROSIUS DOROTHEA
IPC: C07K1/00
Filed: 1991-11-21
Abstract: PCT No. PCT/EP91/02190 Sec. 371 Date Jul. 2, 1992 Sec. 102(e) Date Jul. 2, 1992 PCT Filed Nov. 21, 1991 PCT Pub. No. WO92/09622 PCT Pub. Date Jun. 11, 1992The invention concerns a process for the reactivation of denatured protein, in which the protein is incubated with a solution of Tris base or/and a salt of Tris at a concentration of at least 400 mmol/l and at a pH at which the protein to be treated can take up its native conformation.
Patent IT-8709490-D0 (IT)
Inventor: BELISARIO PINI
IPC: F21V21/30
Filed: 1987-09-22
Abstract: The fitting is intended for use on table lamps or lights which require variable orientation of the reflector. It consists of a stalk (1) with tangential ribs which is entered into the tube forming thecolumn of the lamp. The stalk (1) has a cylindrical top (3) whose axis is perpendicular to the stalk (1). A slotted cover (5) carries the reflector (6) held by screws (7). The shoe (8), of the same profile as the head (3), is held in contact with it by a spring (10) and is the friction element. The cable passes up through the centre of the assembly. The reflector may be tipped through an angle exceeding 120 deg. and may also be rotated.
Patent NO-871352-D0 (NO)
Inventor: NICOLSON GARTH L
IPC: C12N5/09
Filed: 1987-03-31
Abstract: Disclosed are monoclonal antibodies which react with human tumor cells, particularly metastatic human tumor cells, but not with normal human tissues tested. The monoclonal antibodies are prepared against a 580 kilodalton glycoprotein antigen, designated gp580, which is isolated from either rat or human tumor cells. Methods for isolating the glycoprotein antigen are disclosed as well. Moveover, techniques are disclosed for utilizing these antibodies both in the detection and in the prevention of human tumor lesions.
Patent NO-890029-D0 (NO)
Inventor: SUNDREHAGEN ERLING
IPC: G01N33/66
Filed: 1989-01-04
Abstract: PCT No. PCT/EP90/00820 Sec. 371 Date Nov. 1, 1990 Sec. 102(e) Date Nov. 1, 1990 PCT Filed May 11, 1990 PCT Pub. No. WO90/13818 PCT Pub. Date Nov. 15, 1990.A method of assessing glycosylated haemoglobin in a sample, wherein the method comprises the steps of (a) contacting the sample with signal-forming molecules comprising a conjugate of one or more dihydroxyboryl residues or salts thereof, linked to a signal-forming label; (b) separating by selective precipitation from a homogenous solution, glycosylated and non-glycosylated haemoglobin and any molecules bound thereto, from the reaction mixture of step (a) above; and (c) assessing signal-forming molecules selected from the group consisting of signal-forming molecules which have bound to the separated haemoglobin, and non-haemoglobin bound signal-forming molecules. Steps (a) and (b) may be performed simultaneously or sequentially. The sample may optionally be haemolyzed to liberate any cell bound haemoglobin. The invention also comprises an analytical test kit for use in accordance with the method of the invention. The new assay of the invention is particularly useful for the in vitro diagnosis and monitoring of diabetes mellitus.
Patent NO-892395-D0 (NO)
Inventor: SCHNORRER WALTER
IPC: B23K37/06
Filed: 1989-06-12
Abstract: A hindgas implement for protective gas coverage of the root of a welded seam that may be fixed to work pieces to be welded by means of vacuum chambers (11, 13) that are emptied of air via pipe branches (25). After that protective gas is fed to the root of the welded seam via a diffusor (19) and is withdrawn via outlets (21, 23). By means of this, hindgas coverage can also be achieved in welding together of major, extensive work pieces made up of plate as there is no dependence on free edges on which to clamp the hindgas device.
Patent NO-892514-D0 (NO)
Inventor: CARR MICHAEL DOUGLAS
IPC: H04N19/94
Filed: 1989-06-16
Abstract: The current frame of the picture is compared (2) block-by-block with the previous frame to identify changed picture elements (pixels). The resulting matrix is matched ('vector quantised') (4) to one of a set of standard matrices ('VQ shapes'). Only those pixels flagged by the selected VQ shape are transmitted plus a "VQ shape code". This technique is modified in that the current frame is also compared (30) with a "background" frame stored (31) at the transmitter and at the receiver. Where, for any block, all the pixels flagged by the VQ shape are indicated by the second comparison as being the same as the background, the pixels are not sent - instead a shape code plus a "copy background" instruction is transmitted.
Patent NO-892839-D0 (NO)
Inventor: BULLEN DAVID JOHN
IPC: C08L101/00
Filed: 1989-07-07
Abstract: The inclusion of an ester of a linear dibasic acid having from 4 to 14 carbon atoms and a branched alcohol having from 4 to 14 carbon atoms in a composition comprising a silyl polymer and an organometallic silanol condensation catalyst, increases the tendency of the composition to crosslink under ambient conditions. The invention includes compositions crosslinkable by the action of water comprising a silyl polymer, a dicaboxylic acid ester and an organometallic silanol condensation catalyst and also processes for the preparation of the compositions.
Patent NO-920988-D0 (NO)
Inventor: IKKE OPPGITT
IPC: E05D15/10
Filed: 1992-03-13
Abstract: An arrangement for a sliding door, where the frame (19) of the sliding door has an upper sliding rail (1) and a lower sliding rail (2) for the sliding door, and where the sliding door has two vertically disposed sliding door fittings, where each fitting has an upper guide (3) which partly engages with the upper sliding rail (1) and a lower guide (4) which partly engages with the lower sliding rail (2), said lower guide (4) having a caster (6) which can roll along the back (2') of the lower sliding rail and where said upper and lower guides are connected to one another via a mechanism (10, 11, 16) which operates the position of the sliding door fitting. In the operational position of the sliding door said upper and lower guides (3, 4) are lying vertically. On manipulating the sliding door fitting to the locked position the guides (3, 4) come to lie at an inclination relative to the vertical, said sliding door on the transverse rotational turning to the locked position forming a sealing abutment with the frame (19) of the sliding door.
Patent NO-921183-D0 (NO)
Inventor: BLEAKLEY IAN STUART
IPC: C01F11/18
Filed: 1992-03-26
Abstract: The calcium carbonate is prepared by:     (a) slaking quicklime in an aqueous medium; (b) carbonating and neutralising the suspension of slaked lime formed in step (a) using a gas comprising carbon dioxide; and (c) separating the precipitated calcium carbonate formed in step (b) from the aqueous medium in which it is suspended. There is added 0.01% to 15% by weight based on the weight of dry calcium oxide, of a reagent having one or more active hydrogen atoms (or a salt thereof), to the aqueous medium in which the quicklime is slaked in step (a). n
Patent NO-931672-D0 (NO)
Inventor: MIWA AKIRA
IPC: C08K5/5357
Filed: 1993-05-07
Abstract: A preparation comprising a medicinal solution filled in a transparent syringe tube or vessel molded from a resin composition comprising a phosphate represented by general formula (1) as a nucleating agent and a propylene polymer as a base material. The invention can provide a medicated preparation which is excellent in transparency and highly safe because the resin additive does not dissolve in the solution even when the solution is filled for long. The preparation is particularly useful as a medicated syringe preparation. <CHEM>
Patent NO-932545-D0 (NO)
Inventor: KIMBER MICHAEL BROWNING
IPC: A61M5/28
Filed: 1993-07-13
Abstract: PCT No. PCT/AU92/00007 Sec. 371 Date Jul. 14, 1993 Sec. 102(e) Date Jul. 14, 1993 PCT Filed Jan. 9, 1992 PCT Pub. No. WO92/12746 PCT Pub. Date Aug. 6, 1992.A prefilled disposable plastic syringe (1) comprising an open ended barrel (2) having a needle fitting (6) disposed at one end and being sealed at the other end by a moveable stopper (4) wherein said needle fitting end of the barrel (2) is sealed by a frangible closure (7) which is integral with the needle fitting (6), said closure being adapted to cooperate with a hypodermic needle support (21) shaped to fit onto said needle fitting (6) such that application of a downward force on said hypodermic needle support (21) onto said needle fitting (6) causes said closure (7) to separate from the needle fitting and move at least some way into the body of the syringe (1) and thereby reveal the contents of the syringe (1) for injection.
Patent NO-933269-D0 (NO)
Inventor: CHIODI FRANCESCA
IPC: C07K16/00
Filed: 1993-09-14
Abstract: A polypeptide linked to a solid matrix useful as a solid support of a diagnostic kit is disclosed. The polypeptide has the formula: X-Glu-Thr-Gly-Gln-Glu-Thr-Ala-Tyr-Phe-B-Leu-Lys-Leu-Ala-Gly-Arg-Trp-Pro-Val-Lys-Z, wherein B is Ile or Leu, X is a chain of from 1 to 20 amino acid residues or an amino-terminal group and Z is a chain of from 1 to 20 amino acid residues or a carboxy-terminal group. The polypeptide immunologically mimics HIV endonuclease.
Patent NO-944669-D0 (NO)
Inventor: UNDHEIM KJELL
IPC: C07K7/06
Filed: 1994-12-02
Abstract: PCT No. PCT/GB93/01171 Sec. 371 Date Nov. 30, 1994 Sec. 102(e) Date Nov. 30, 1994 PCT Filed Jun. 2, 1993 PCT Pub. No. WO93/24523 PCT Pub. Date Dec. 9, 1993Dipeptide compounds are disclosed, the two peptide chains being joined together at a C alpha -atom of a non-terminal amino acid by a divalent bridging group -A-. The C alpha -atoms joined to group -A- are located in equivalent positions in each peptide and each lack their native  alpha -side chain. The bridged dipeptide compounds disclosed have a stimulating activity on cell division, especially for myelopoietic and bone marrow cells.
Patent NO-944996-D0 (NO)
Inventor: SEIM TORSTEIN
IPC: G01N21/75
Filed: 1994-12-23
Abstract: PCT No. PCT/GB93/01357 Sec. 371 Date Dec. 23, 1994 Sec. 102(e) Date Dec. 23, 1994 PCT Filed Jun. 29, 1993 PCT Pub. No. WO94/00749 PCT Pub. Date Jan. 6, 1994.Light measurement apparatus includes an elongate member which has at one end thereof light emitter(s) and light detector(s). At least the end of the elongate member that has the light emitter(s) and light detector(s) is surrounded by a resiliently biased sheath. In use, when the elongate member is applied to a surface to take a reading, the sheath defines a light-tight enclosure. A related method for determining intensity and/or color of a colored spot on a surface of a test site uses the light measurement apparatus. The method includes bringing the end of the elongate member into contact with the surface, pressing the resiliently biased sheath towards the surface to define a light-tight enclosure, and measuring the intensity and/or color of the colored spot on the surface.
Patent NO-961190-D0 (NO)
Inventor: OPPONG DAVID
IPC: A01N37/04
Filed: 1996-03-22
Abstract: Compositions comprising 2-(thiocyanomethylthio)benzothiazole and at least one organic acid or its salt are disclosed which are synergistically effective compared to the respective components alone in controlling the growth of microorganisms in or on a material or medium. Methods to control the growth of microorganisms and prevent spoilage caused by microorganisms with the use of the compositions of the present invention are also disclosed.
Patent NO-964308-D0 (NO)
Inventor: REUTELINGSPERGER CHRISTIAAN PE
IPC: G01N33/533
Filed: 1996-10-10
Abstract: PCT No. PCT/NL95/00134 Sec. 371 Date Oct. 11, 1996 Sec. 102(e) Date Oct. 11, 1996 PCT Filed Apr. 11, 1995 PCT Pub. No. WO95/27903 PCT Pub. Date Oct. 19, 1995A procedure to measure apoptosis in physiology and pathology in order to support clinical diagnosis and monitor efficacies of drugs and therapies. In particular a method for detecting and/or optionally quantifying and/or optionally isolating apoptotic cells in a sample, comprising contacting the sample with a detectable reagent having high affinity for phosphatidyl serine; and qualitatively and/or optionally quantitatively detecting cells that have reacted with the detectable reagent having high affinity for phosphatidyl serine preferably intact cells, detection occurring before or after an optional step for isolating apoptotic cells from non-apoptotic cells, which isolation can occur due to the fact that apoptotic cells have been provided with a detectable reagent having high affinity for phosphatidyl serine, the reagent also being selectable in a manner known per se. A suitable reagent having high affinity for phosphatidyl serine is a polypeptide or protein classified as an annexin. A kit for carrying out such methods is provided.